SINO BIOPHARM (01177.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec11

Zentelxin (Cumbexil) Approved for Market by Chong Kun Dang Pharmaceutical

10:29

Dec4

ChinaBiot's Innovative Drug TQF3250 Capsules Clinical Trial Application Approved by Chinese and US Authorities

09:26

Dec3

China Biopharmaceutical's Rotigotine Patch Approved for Market Launch by NMPA

08:34

Dec1

China Biologic Completes First Patient Enrollment for TRD208 Phase I Clinical Trial

10:17

Nov27

Zhangdaye Pharma and China Biologic Donate HK$10 Million in Cash and Medicines to Aid Fire Victims

23:20

Nov26

China Bio Pharmaceutical's Subsidiary LM-350 Receives Clinical Trial Approval

03:49

Schedules & Filings

Schedules

Filings

Sep23

Distribution Plan(CST)

Cash dividend 0.05 HKD

Sep1

Distribution Plan(CST)

Cash dividend 0.05 HKD

Aug29

Distribution Plan(CST)

Cash dividend 0.05 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More